[DPHARMA] YoY Cumulative Quarter Result on 31-Dec-2013 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
QoQ- 33.51%
YoY- 24.07%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 312,940 270,680 176,961 162,405 135,310 138,132 131,437 15.54%
PBT 31,479 49,755 46,509 40,175 35,298 34,728 35,408 -1.93%
Tax -4,653 0 0 -7,900 -9,284 -8,023 -6,739 -5.98%
NP 26,826 49,755 46,509 32,275 26,014 26,705 28,669 -1.10%
-
NP to SH 27,115 38,775 35,271 32,275 26,014 26,705 28,669 -0.92%
-
Tax Rate 14.78% 0.00% 0.00% 19.66% 26.30% 23.10% 19.03% -
Total Cost 286,114 220,925 130,452 130,130 109,296 111,427 102,768 18.58%
-
Net Worth 454,703 270,177 192,942 181,850 169,354 163,783 156,881 19.38%
Dividend
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div 18,132 15,843 25,679 24,293 19,434 24,983 222 108.15%
Div Payout % 66.87% 40.86% 72.81% 75.27% 74.71% 93.56% 0.77% -
Equity
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 454,703 270,177 192,942 181,850 169,354 163,783 156,881 19.38%
NOSH 278,959 278,959 138,807 138,817 138,815 138,799 138,832 12.32%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 8.57% 18.38% 26.28% 19.87% 19.23% 19.33% 21.81% -
ROE 5.96% 14.35% 18.28% 17.75% 15.36% 16.31% 18.27% -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 112.18 162.30 127.49 116.99 97.47 99.52 94.67 2.86%
EPS 9.62 19.17 25.41 23.25 18.74 19.24 20.65 -11.94%
DPS 6.50 9.50 18.50 17.50 14.00 18.00 0.16 85.30%
NAPS 1.63 1.62 1.39 1.31 1.22 1.18 1.13 6.29%
Adjusted Per Share Value based on latest NOSH - 138,792
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 32.53 28.14 18.40 16.88 14.07 14.36 13.66 15.54%
EPS 2.82 4.03 3.67 3.36 2.70 2.78 2.98 -0.91%
DPS 1.88 1.65 2.67 2.53 2.02 2.60 0.02 113.08%
NAPS 0.4727 0.2809 0.2006 0.189 0.1761 0.1703 0.1631 19.38%
Price Multiplier on Financial Quarter End Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 1.98 2.62 2.50 2.58 2.13 2.02 2.39 -
P/RPS 1.76 1.61 1.96 2.21 2.19 2.03 2.52 -5.80%
P/EPS 20.37 11.27 9.84 11.10 11.37 10.50 11.57 9.87%
EY 4.91 8.87 10.16 9.01 8.80 9.52 8.64 -8.98%
DY 3.28 3.63 7.40 6.78 6.57 8.91 0.07 89.76%
P/NAPS 1.21 1.62 1.80 1.97 1.75 1.71 2.12 -8.91%
Price Multiplier on Announcement Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 24/02/17 23/02/16 24/02/15 26/02/14 25/02/13 22/02/12 23/02/11 -
Price 2.23 2.61 2.92 2.60 2.17 2.12 2.45 -
P/RPS 1.99 1.61 2.29 2.22 2.23 2.13 2.59 -4.29%
P/EPS 22.94 11.23 11.49 11.18 11.58 11.02 11.86 11.61%
EY 4.36 8.91 8.70 8.94 8.64 9.08 8.43 -10.39%
DY 2.91 3.64 6.34 6.73 6.45 8.49 0.07 86.01%
P/NAPS 1.37 1.61 2.10 1.98 1.78 1.80 2.17 -7.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment